<p>The invention provides crystalline naphthalene-1,5-disulfonic acid salts of biphenyl-2-ylcarbamic acid 1-{2-[5-(4-hydroxybenzylamino)pentylcarbamoyl]ethyl} piperidin-4-yl ester, and pharmaceutically acceptable solvates thereof. The invention also provides pharmaceutical compositions comprising the crystalline compounds or prepared using such compounds; processes and intermediates for preparing the crystalline compounds; and methods of using the compounds to treat pulmonary disorders.</p>
申请公布号
WO2006099166(A1)
申请公布日期
2006.09.21
申请号
WO2006US08645
申请日期
2006.03.09
申请人
THERAVANCE, INC.;DALZIEL, SEAN M.;HUBBARD, CRISTIN;MALATHONG, VIENGKHAM
发明人
DALZIEL, SEAN M.;HUBBARD, CRISTIN;MALATHONG, VIENGKHAM